Drug–MicroRNA Cross-Talk

Paloma del C. Monroig, George A. Calin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Regenerative medicine is an interdisciplinary field that aims to repair, replace, or regenerate cells, tissues, or organs that are lost or damaged because of disease, injury, or aging. Understanding the roles of microRNAs (miRNAs) in these biological processes is thus a novel therapeutic approach. Several drugs can alter basal levels of miRNAs in a tissue-dependent manner, causing some miRNAs to increase and others to nearly disappear. When miRNA levels are altered during treatment, their expression can determine whether or not a therapy is successful. Key interactions that link miRNAs in drug efficacy and toxicity are outlined in this chapter. By understanding the pharmacogenomic mechanisms involving miRNAs and drugs, researchers aim to elucidate potential clinical applications in regenerative medicine.

Original languageEnglish (US)
Title of host publicationMicroRNA in Regenerative Medicine, Second Edition
PublisherElsevier
Pages837-862
Number of pages26
ISBN (Electronic)9780128207192
ISBN (Print)9780128207222
DOIs
StatePublished - Jan 1 2023

Keywords

  • Drug efficacy
  • Drug metabolism
  • Drug toxicity
  • microRNAs
  • miRNAs
  • Pharmacogenomics
  • Protein regulation
  • Regenerative medicine

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Drug–MicroRNA Cross-Talk'. Together they form a unique fingerprint.

Cite this